Home/Filings/4/0001415889-24-006211
4//SEC Filing

Morisset Valerie 4

Accession 0001415889-24-006211

CIK 0001768446other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 11:07 AM ET

Size

11.7 KB

Accession

0001415889-24-006211

Insider Transaction Report

Form 4
Period: 2023-09-20
Morisset Valerie
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-20$0.00/sh+15,297$3487,460 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-09-205,4310 total
    Exercise: $0.00Exp: 2030-02-03Common Stock (5,431 underlying)
  • Exercise/Conversion

    Common Stock

    2023-09-20$0.00/sh+5,431$11472,163 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-09-2015,29745,893 total
    Exercise: $0.00Exp: 2031-02-25Common Stock (15,297 underlying)
Footnotes (2)
  • [F1]The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of April 1, 2019 (the "April 2019 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the April 2019 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the April 2019 Vesting Commencement Date.
  • [F2]The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of February 26, 2021 (the "February 2021 Vesting Commencement Date") and 1/48thof the total number of shares each monthly anniversary of the February 2021 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the February 2021Vesting Commencement Date.

Issuer

Eliem Therapeutics, Inc.

CIK 0001768446

Entity typeother

Related Parties

1
  • filerCIK 0001868517

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 11:07 AM ET
Size
11.7 KB